Meritage Portfolio Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-157,102
| Closed | -$5.31M | – | 333 |
|
|
2024
Q4 | $5.31M | Sell |
157,102
-2,544
| -2% | -$86K | 0.33% | 79 |
|
|
2024
Q3 | $6.53M | Sell |
159,646
-3,655
| -2% | -$149K | 0.4% | 70 |
|
|
2024
Q2 | $6.29M | Sell |
163,301
-2,209
| -1% | -$85K | 0.4% | 70 |
|
|
2024
Q1 | $7.1M | Sell |
165,510
-11,512
| -7% | -$493K | 0.45% | 61 |
|
|
2023
Q4 | $6.56M | Sell |
177,022
-1,708
| -1% | -$63.3K | 0.43% | 63 |
|
|
2023
Q3 | $6.48M | Sell |
178,730
-4,298
| -2% | -$156K | 0.48% | 60 |
|
|
2023
Q2 | $6.52M | Sell |
183,028
-11,238
| -6% | -$401K | 0.46% | 63 |
|
|
2023
Q1 | $6.91M | Buy |
194,266
+139
| +0.1% | +$4.95K | 0.52% | 60 |
|
|
2022
Q4 | $6.82M | Buy |
194,127
+104,907
| +118% | +$3.69M | 0.53% | 57 |
|
|
2022
Q3 | $2.63M | Sell |
89,220
-9,044
| -9% | -$266K | 0.22% | 134 |
|
|
2022
Q2 | $5.35M | Buy |
98,264
+1,368
| +1% | +$74.4K | 0.41% | 79 |
|
|
2022
Q1 | $5.28M | Buy |
+96,896
| New | +$5.28M | 0.33% | 94 |
|
|
2016
Q2 | – | Sell |
-99,651
| Closed | -$5.05M | – | 197 |
|
|
2016
Q1 | $5.05M | Buy |
99,651
+8,372
| +9% | +$424K | 0.57% | 76 |
|
|
2015
Q4 | $4.6M | Sell |
91,279
-2,706
| -3% | -$136K | 0.52% | 90 |
|
|
2015
Q3 | $4.52M | Sell |
93,985
-22,969
| -20% | -$1.1M | 0.52% | 86 |
|
|
2015
Q2 | $6.09M | Sell |
116,954
-748
| -0.6% | -$38.9K | 0.64% | 48 |
|
|
2015
Q1 | $6.79M | Buy |
117,702
+12,372
| +12% | +$714K | 0.68% | 34 |
|
|
2014
Q4 | $5.63M | Sell |
105,330
-819
| -0.8% | -$43.8K | 0.6% | 59 |
|
|
2014
Q3 | $6.1M | Buy |
106,149
+26,892
| +34% | +$1.55M | 0.69% | 34 |
|
|
2014
Q2 | $5.3M | Buy |
79,257
+21,524
| +37% | +$1.44M | 0.58% | 64 |
|
|
2014
Q1 | $3.86M | Buy |
57,733
+1,504
| +3% | +$100K | 0.46% | 123 |
|
|
2013
Q4 | $3.75M | Sell |
56,229
-693
| -1% | -$46.3K | 0.46% | 115 |
|
|
2013
Q3 | $3.57M | Buy |
56,922
+1,932
| +4% | +$121K | 0.46% | 112 |
|
|
2013
Q2 | $3.44M | Buy |
+54,990
| New | +$3.44M | 0.49% | 104 |
|